SpyGlass Pharma

SGP · NASDAQ

$26.16+$1.56 (+6.34%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $24.60

SGP analyst rating

BuyConsensus of 6 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy6
Hold0
Underperform0
Sell0

12-month price target · 7 analysts

Average $44.88 (+71.6% upside)

Low: $37.37
Now: $26.16
High: $65.10

Upgrades and downgrades

The latest rating actions, newest first

SGP analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
HC Wainwright & Co.	Oct 5, 2026	Maintains	Buy	$37.00	40%
Raymond James	Aug 14, 2026	Initiates	Outperform	$39.00	51%
HC Wainwright & Co.	Mar 10, 2026	Initiates	Buy	$37.00	40%
Citigroup	Mar 3, 2026	Initiates	Buy	$42.00	42%
Leerink Partners	Mar 3, 2026	Initiates	Outperform	$42.00	55%
Jefferies	Mar 3, 2026	Initiates	Buy	$62.00	25%
Stifel	Mar 3, 2026	Initiates	Buy	$42.00	40%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.